San Donato Hospital
Die Gesamtkosten für die Behandlung von Prostatakrebs in Italien variieren je nach den gewählten Verfahren. Ein Zweitmeinungsdienst, der die Überprüfung von MRTs und eine schriftliche Schlussfolgerung eines Spezialisten umfasst, kostet ungefähr 360 €. Die robotergestützte Prostataoperation liegt zwischen 21.700 € und 31.000 €. Eine umfassende Behandlung, einschließlich Krankenhausaufenthalt, präoperativer Tests und medizinischer Betreuung, kostet zwischen 20.600 € und 30.000 €. Der endgültige Behandlungsplan und die Kosten werden nach einer individuellen Bewertung durch den Gesundheitsdienstleister festgelegt.
| Italien | Türkei | Österreich | |
| Transurethrale Resektion der Prostata (TURP) | von $3,600 | von $3,580 | von $5,500 |
| Tomotherapie | von $32,000 | von $12,000 | von $30,000 |
| Strahlentherapie bei Prostatakrebs | von $18,000 | von $4,000 | von $14,000 |
| Robotische da Vinci-Prostatektomie | von $24,480 | von $17,000 | von $20,000 |
| Protonenstrahltherapie | von $70,000 | von $70,000 | von $80,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Prostatakrebs-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Prostatakrebs einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Prostatakrebs-Behandlungsreise nie allein.
Prof. Montorsi hat über 8.000 urologische Operationen durchgeführt und ist am San Raffaele auf minimalinvasive und robotergestützte Techniken bei Prostatakrebs spezialisiert.
Leiter der Strahlentherapie am San Raffaele Krankenhaus – Prof. Di Muzio spezialisiert sich auf hochpräzise hypofraktionierte Methoden bei Prostatakrebs und verfügt über mehr als 25 Jahre Erfahrung.
Dr. Alessandro Calarco ist ein erfahrener Urologe mit Spezialisierung auf minimalinvasive und endourologische Verfahren. Er führt perkutane Lithotripsie, Ureterorenoskopie, Tumorablation und fortgeschrittene rekonstruktive Eingriffe durch. Für seine klinische Arbeit und Forschung wurde Dr. Calarco international anerkannt. Er absolvierte eine Fachausbildung in Schweden und Großbritannien.
Dr. Calarco schloss sein Medizinstudium an der Università Cattolica del Sacro Cuore in Rom mit Auszeichnung ab. Dort spezialisierte er sich in Urologie und promovierte in onkologischer Urologie. Seine Forschung konzentriert sich auf Prostatakrebs-Biomarker und Exosomen. Zudem entwickelte er klinische Protokolle für hormonrefraktären Prostatakrebs mit.
Er ist nationaler Leiter der Urologie bei SPIGC und Mitglied des European Board of Urology. Dr. Calarco hält ein internationales Patent für ein Gerät zur Verbesserung der perkutanen Nephrolithotripsie. Er hat zahlreiche Publikationen veröffentlicht und mehrere Auszeichnungen für chirurgische Innovation und Lehre erhalten.
Geschrieben von Olena Sikoza
Geschrieben von Anna Leonova
Italy offers elite prostate cancer care at IRCCS-accredited facilities like San Raffaele in Milan and Ospedale San Carlo di Nancy in Rome. These centers feature the da Vinci robotic system for nerve-sparing surgery. Leading specialists like Prof. Francesco Montorsi have performed over 8,000 specialized urological procedures.
Bookimed Expert Insight: While many search for general hospital rankings, our data suggests focusing on surgeon-specific caseloads within Milan's IRCCS-accredited cluster. San Raffaele stands out not just for volume, but for clinical research integration. Their specialists often serve as national coordinators for advanced protocols like brachytherapy, ensuring patients access treatment standards that regional centers may not yet offer.
Patient Consensus: Patients emphasize that accessing high-volume surgeons who perform over 200 annual prostatectomies is more critical than the hospital's general reputation. Many recommend bringing original pathology slides for a second opinion at major Milanese centers to ensure accurate staging before surgery.
Italy offers advanced medical technologies focusing on robotic surgery and precision oncology. Systems like Da Vinci enable minimally invasive prostatectomies with high success rates. Specialized centers also provide proton therapy and high-precision hypofraction methods. These institutions maintain international accreditations for complex oncology and urology care.
Bookimed Expert Insight: Data shows Italy's leading research hospitals achieve massive surgical volumes. San Raffaele in Milan performs over 52,000 operations annually. This high frequency allows surgeons like Dr. Francesco Montorsi to complete over 8,000 procedures. Patients benefit from this extreme specialization. It often leads to better preservation of urinary and sexual function compared to lower-volume centers.
Patient Consensus: Patients note that Italian centers offer high robotic expertise with faster scheduling than other European destinations. They emphasize confirming the surgeon performs over 300 robotic cases annually to ensure the best functional outcomes.
Average waiting times for prostate cancer treatment in Italy range from 30 to 93 days depending on clinical urgency. The Italian National Healthcare System (SSN) prioritizes urgent cases within 72 hours. Non-urgent oncological surgeries typically proceed within approximately 29 to 35 days.
Bookimed Expert Insight: High-volume research centers like San Raffaele in Milan manage over 52,000 operations annually. Patients can significantly reduce wait times by accessing these accredited facilities through private or Libera professione channels. This approach bypasses standard public queues while maintaining access to top researchers like Prof. Dr. Francesco Montorsi.
Patient Consensus: Patients note that requesting a specific urgency code from their urologist is vital for faster scheduling. Many suggest using online regional tracking systems to monitor and appeal potential treatment delays.
Patients should prioritize questions about specific Gleason scores and the surgeon's personal robotic prostatectomy volume. Inquire about multidisciplinary tumor boards at facilities like San Raffaele. Clarify if treatments like da Vinci robotic surgery or proton-beam therapy fit your specific cancer stage and grade.
Bookimed Expert Insight: Italian centers of excellence like San Raffaele and San Carlo di Nancy often combine clinical care with intensive research. High-volume specialists like Dr. Francesco Montorsi have performed over 8,000 surgeries. This level of expertise often leads to better preservation of nerve function and faster recovery. Always ask if your case will be reviewed by a multidisciplinary equipe including radiation oncologists.
Patient Consensus: Patients note it is essential to bring a printed PSA history and biopsy report. They emphasize asking for a written staging summary to avoid confusion during follow-up care.
Prostate cancer treatments in Italy typically involve surgery, radiotherapy, or hormone therapy. Common side effects include urinary incontinence, erectile dysfunction, bowel changes, and fatigue. Clinics in Milan and Rome use robotic systems and high-precision radiation to reduce these impacts.
Bookimed Expert Insight: Italian centres of excellence show a strong trend toward volume-based safety. San Raffaele in Milan performs over 52,000 operations annually. Prof. Dr Francesco Montorsi there has personally handled over 8,000 urology cases. High surgical volume often leads to better nerve-sparing outcomes. This is vital for preserving sexual function after a prostatectomy.
Patient Consensus: Patients in Italy note that side effects vary greatly by treatment. They suggest planning early for urinary aids. They also recommend discussing sexual rehabilitation before starting any hormone or radiation cycles.
Italy offers Australian patients access to high-volume IRCCS-accredited research hospitals. These centres specialise in robotic prostatectomy and radiotherapy. Leading clinics in Milan and Rome use the Da Vinci robotic system. They also use PSMA PET/CT imaging for precise prostate cancer staging and treatment.
Bookimed Expert Insight: Italian urology stands out because top specialists often work as both researchers and surgeons. Prof. Francesco Montorsi at San Raffaele has published over 1,000 papers. He leads a department that handles 300,000 patients annually. This massive case volume means these teams manage complex cases that smaller centres rarely see.
Patient Consensus: Patients travel to Italy to confirm treatment plans through multidisciplinary teams. They often seek second opinions for complex pathology reviews. Many suggest comparing a clinic's specific prostate cancer case volume when choosing a robotic surgeon.
Italy offers prostate cancer treatments including robotic surgery, high-precision radiotherapy, and targeted nuclear medicine. Centres in Milan and Rome use Da Vinci systems for nerve-sparing prostatectomies. Patients also access specialised techniques like Tomotherapy and PSMA-targeted therapies at JCI-accredited facilities.
Bookimed Expert Insight: Italian urology excellence is concentrated in Milan research hospitals like San Raffaele. This facility alone performs over 52,000 operations annually. Prof. Francesco Montorsi has authored over 1,000 papers. This shows academic depth rarely seen outside major US teaching hospitals.
Patient Consensus: Patients note it is important to focus on recovery timelines and local logistics. They suggest prioritising clinics that offer integrated diagnostic staging like PSMA PET-CT.
Italy offers active clinical trials for advanced prostate cancer. Research centres in Milan and Rome focus on targeted agents, radioligand therapy, and combination treatments. Italian institutions participate in international phase 3 studies for metastatic cases. Patients find options for PARP inhibitors and immunotherapy protocols through major research hospitals.
Bookimed Expert Insight: Italy's IRCCS-accredited centres like San Raffaele and San Donato have official recognition for research-led care. This status allows these clinics to provide faster access to experimental protocols for metastatic cases. Professor Francesco Montorsi at San Raffaele has performed over 8,000 surgeries. This high-volume surgical perspective often informs these clinical trial designs.